Search Results for: Laser
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
Cosmetic Laser Dermatology Medical Director Leads Promising Acne Research Study Mitchel Goldman, MD, Medical Director of Cosmetic Laser Dermatology and coordinating investigator of a groundbreaking clinical study, shares his enthusiasm about the potential breakthrough for acne treatment. “Ameluz® PDT has shown significant benefits in other skin conditions, and we expect it will become a valuable
